BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Racz RR, Kollo M, Racz G, et al. (2022) jULIEs: nanostructured polytrodes for low traumatic extracellular recordings and stimulation in the mammalian brain. Journal of Neural Engineering |
Sakuma R, Lin KT, Kim S, et al. (2022) Passive near-field imaging via grating-based spectroscopy. The Review of Scientific Instruments. 93: 013704 |
Wang G, Mohanty B, Williams ML, et al. (2022) Selective binding of small molecules to Vibrio cholerae DsbA offers a starting point for the design of novel antibacterials. Chemmedchem |
Park JR, Verderosa AD, Totsika M, et al. (2021) Thermoresponsive Polymer-Antibiotic Conjugates Based on Gradient Copolymers of 2-Oxazoline and 2-Oxazine. Biomacromolecules |
Santos-Martin C, Wang G, Subedi P, et al. (2021) Structural bioinformatic analysis of DsbA proteins and their pathogenicity associated substrates. Computational and Structural Biotechnology Journal. 19: 4725-4737 |
Duncan LF, Wang G, Ilyichova OV, et al. (2021) Elaboration of a benzofuran scaffold and evaluation of binding affinity and inhibition of Escherichia coli DsbA: A fragment-based drug design approach to novel antivirulence compounds. Bioorganic & Medicinal Chemistry. 45: 116315 |
Dhouib R, Vagenas D, Hong Y, et al. (2021) Antivirulence DsbA inhibitors attenuate serovar Typhimurium fitness without detectable resistance. Faseb Bioadvances. 3: 231-242 |
Subedi P, Paxman JJ, Wang G, et al. (2021) BcfH is a trimeric thioredoxin-like bifunctional enzyme with both thiol oxidase and disulfide isomerase activities. Antioxidants & Redox Signaling |
Lim Y, Tang KD, Karpe AV, et al. (2021) Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer. Head & Neck |
Verderosa AD, Dhouib R, Hong Y, et al. (2021) A high-throughput cell-based assay pipeline for the preclinical development of bacterial DsbA inhibitors as antivirulence therapeutics. Scientific Reports. 11: 1569 |